Somasundaram, Rajasekharan
Zhang, Gao
Fukunaga-Kalabis, Mizuho
Perego, Michela
Krepler, Clemens
Xu, Xiaowei
Wagner, Christine
Hristova, Denitsa
Zhang, Jie http://orcid.org/0000-0003-0242-8812
Tian, Tian
Wei, Zhi
Liu, Qin http://orcid.org/0000-0001-9964-580X
Garg, Kanika
Griss, Johannes
Hards, Rufus
Maurer, Margarita
Hafner, Christine
Mayerhöfer, Marius
Karanikas, Georgios
Jalili, Ahmad
Bauer-Pohl, Verena
Weihsengruber, Felix
Rappersberger, Klemens
Koller, Josef
Lang, Roland
Hudgens, Courtney http://orcid.org/0000-0001-8312-7485
Chen, Guo
Tetzlaff, Michael
Wu, Lawrence
Frederick, Dennie Tompers
Scolyer, Richard A.
Long, Georgina V.
Damle, Manashree
Ellingsworth, Courtney
Grinman, Leon
Choi, Harry
Gavin, Brian J.
Dunagin, Margaret
Raj, Arjun
Scholler, Nathalie
Gross, Laura
Beqiri, Marilda
Bennett, Keiryn http://orcid.org/0000-0001-9356-7708
Watson, Ian
Schaider, Helmut
Davies, Michael A.
Wargo, Jennifer
Czerniecki, Brian J.
Schuchter, Lynn
Herlyn, Dorothee
Flaherty, Keith
Herlyn, Meenhard
Wagner, Stephan N. http://orcid.org/0000-0003-4941-7029
Article History
Received: 23 March 2017
Accepted: 30 June 2017
First Online: 19 September 2017
Competing interests
: G.L. has consulting or advisory role for GSK, BMS, Novartis, Genentech, Amgen, Merck, Pierre Fabre, Array, and Roche. K.F. has consulting or advisory role for Novartis, Roche, and Array. J.W. is an advisory board member for GSK, Roche/Genentech, Novartis, and BMS. M.A.D. is an advisory board member for GSK, Roche/Genentech, Novartis, Sanofi, and Vaccinex. R.Sc. received an honorarium from Roche. The remaining authors declare no competing financial interests.